Product Information
AUROVELA 24 FE 1 MG-20 MCG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1748 per EA under NDC 65862093487. Its NADAC has been published 193 times since Jan 25, 2023.
FDA first approved this application on Jun 15, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AUROVELA 24 FE 1 MG-20 MCG TAB
Norethindrone Acetate and Ethinyl Estradiol and Ferrous FumarateManufacturer
Aurobindo Pharma LimitedNDC
65862093487
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA207504FDA Approved
6/15/2017
TE Code
AB
On Market Since
6/15/2017
Price Statistics
The NADAC for AUROVELA 24 FE 1 MG-20 MCG TAB has been published 193 times since Jan 25, 2023, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1748 per EA |
|---|---|
| All-time high | $0.4192 (Feb 15, 2023) |
| All-time low | $0.1748 (Sep 23, 2026) |
| 52-week high | $0.2213 |
| 52-week low | $0.1748 |
| Median price | $0.2216 |
| Average price | $0.2548 |
| Largest weekly change | +33.9% (Aug 21, 2024) |
| Weeks tracked | 193 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AUROVELA 24 FE 1 MG-20 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AUROVELA 24 FE 1 MG-20 MCG TAB, manufactured by Aurobindo Pharma Limited, is $0.1748 per EA (NDC 65862093487), effective Sep 30, 2026.
How has the price of AUROVELA 24 FE 1 MG-20 MCG TAB changed over time?
Over the history we have for it, the NADAC for AUROVELA 24 FE 1 MG-20 MCG TAB has declined 58.3%. It has been tracked across 193 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for AUROVELA 24 FE 1 MG-20 MCG TAB?
Since Jan 25, 2023, the NADAC for AUROVELA 24 FE 1 MG-20 MCG TAB has ranged from a low of $0.1748 (Sep 23, 2026) to a high of $0.4192 (Feb 15, 2023), with a median of $0.2216 per EA.
Are there cheaper alternatives to AUROVELA 24 FE 1 MG-20 MCG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TARINA FE 1-20 EQ TABLET, is $0.1287 per EA — about 26% below AUROVELA 24 FE 1 MG-20 MCG TAB.
Who manufactures AUROVELA 24 FE 1 MG-20 MCG TAB?
AUROVELA 24 FE 1 MG-20 MCG TAB (NDC 65862093487) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.